The Limited Times

Now you can see non-English news...

Coronavirus: the Russian Sputnik V vaccine would arrive in Argentina on December 23

2020-12-16T15:52:41.179Z


It would be the first 600,000 doses to vaccinate 300,000 people in risk groups. 12/16/2020 12:39 PM Clarín.com Society Updated 12/16/2020 12:39 PM The first doses of the Russian Sputnik V vaccine against the coronavirus would arrive in Argentina next Wednesday, December 23 , as high government sources confirmed to Clarín . Last Thursday, when announcing the signing of the agreement with Russia, President Alberto Fernández had anticipated that before the end of the year 600,


12/16/2020 12:39 PM

  • Clarín.com

  • Society

Updated 12/16/2020 12:39 PM

The first doses of the Russian Sputnik V vaccine against the coronavirus

would arrive in Argentina next Wednesday, December 23

, as

high government sources

confirmed to

Clarín

.

Last Thursday, when announcing the signing of the agreement with Russia, President Alberto Fernández had anticipated that before the end of the year 600,000 doses would arrive, with which 300,000 people could be vaccinated.

However, in recent days the voices that questioned that statement have grown.

The problem, in addition to the logistics, is that everything indicates that the Russian vaccine will set foot on Argentine soil

without the endorsement of the regulatory entities

of the United States (FDA) and the European Community (EMA).

That is why officials from the Anmat - the body that must authorize the country - traveled to Russia to evaluate the vaccine and allow its emergency application.

A dose of the vaccine developed in Moscow by the Gamaleya Institute.

Photo: EFE

The contract contemplates that between January and February another 20 million doses will arrive and a preference in favor of Argentina to be able to vaccinate another 5 million people in March.

The official position is that it was important to close this acquisition in case the rest of the vaccines with which they also have contracts delay their arrival.

In this sense, the Minister of Health, Ginés González García, admitted that the possibility of reaching a purchase agreement with Pfizer is still immature.

"In the negotiation we were asked for a law to have some security, to give them that immunity, and later it appeared in the negotiation that it was not enough, that a new law had to be made and that the contract was not signed by me and signed by President.

Strictly speaking, they are unacceptable conditions

and we have asked you to reveal that, "said González García about the vaccine developed by the US laboratory.

The Gamaleya Center, which develops Sputnik V, assured that it achieved an

efficacy against the coronavirus of 91.4% in 22 thousand volunteers

and highlighted the importance of the contract signed with Argentina to receive the drug.

No unexpected adverse events were identified as part of the investigation, a statement said.

And he adds that the health conditions of the participants will be monitored for at least 6 months after receiving the first vaccine.

AFG

Look also

Vaccine against the coronavirus: the plot of why Argentina has not yet managed to close an agreement with Pfizer

Fernán Quirós and the lack of data on the Russian vaccine against coronavirus: "There is only journalistic information"

Source: clarin

All life articles on 2020-12-16

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.